Drug Trial Radar · NCT00440843
Zyprexa and Task Engagement in Schizophrenia
Last checked: Nov 19, 2026Latest source record: Dec 23, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Withdrawn
Enrollment
0
Actual
Start
Feb 2007
Primary completion
Jun 2012
Study completion Jun 2012
Sponsor
- Lead sponsor
- VA Connecticut Healthcare SystemFederal agency
- Sponsor type
- Federal agency
- Collaborators
- Clinical Trials Network of Columbia U, Cornell U, and NY Presbyterian Hospital; Eli Lilly and Company
- First posted
- Feb 27, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Individuals with schizophrenia frequently have impairments in attention. These impairments have been shown to be related to overall functioning. Some research suggests that Olanzapine may be associated with improvement in various aspects of attention. The primary purpose of this study is to determine whether switching from a typical antipsychotic to Olanzapine improves task engagement. Individuals who taking typical antipsychotics will be randomly assigned to either 1) remain on their typical antipsychotic medications, or 2) be switched from their typical antipsychotic medications to Olanzapine. All participants will be enrolled in a twice-weekly 20 session cognitive training program that is specifically designed to target attention deficits and promote active engagement. Improvements in attention will be compared between individuals who remained on their typical antipsychotic medications and those that were switched to Olanzapine.
Conditions
- Schizophrenia
- Schizoaffective Disorder
Interventions
Olanzapine (Zyprexa)Drug
OLZ
TypicalsDrug
Stay on typicals regimen
Primary outcomes
What the sponsor says the trial is designed to measure.
- PupillometryTime frame: Baseline, post
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Columbia University Medical Center
New York, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.